Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement (Q41404377)

30 September 2017

title

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement (English)

1 reference

30 September 2017

2

Sodroski J

1 reference

30 September 2017

Marschang P

1

1 reference

30 September 2017

Würzner R

series ordinal

3

1 reference

30 September 2017

Dierich MP

series ordinal

4

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

European Journal of Immunology

30 September 2017

published in

1 reference

30 September 2017

volume

25

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

285-290

1 reference

Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

HIV and complement: role of the complement system in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

Human serum lyses RNA tumour viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Inactivation of lysis of oncornaviruses by human serum

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

HIV and HIV-infected cells differentially activate the human complement system independent of antibody

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Human T-cell leukaemia virus is not lysed by human serum

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

The regulators of complement activation (RCA) gene cluster

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

The control of homologous lysis

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Structural and functional relationships among receptors and regulators of the complement system

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Nonrandom association of cellular antigens with HTLV-III virions.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Use of eukaryotic expression technology in the functional analysis of cloned genes

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

The establishment of rodent cell lines persistently producing HIV-1

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Complement evasion strategies of microorganisms

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

The mechanism by which microorganisms avoid complement attack

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

https://api.crossref.org/works/10.1002/EJI.1830250147

7 January 2021

Identifiers

DOI

10.1002/EJI.1830250147

1 reference

30 September 2017

1 reference